Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface anionic membranes and heparan sulfate proteoglycans (HSPGs) constitute a negatively charged interface on the plasma membrane that plays a pivotal role in cellular communication and pathogen entry. HSPGs, including the syndecan and glypican families, consist of core proteins decorated with heparan sulfate glycosaminoglycan chains that bind a diverse array of ligands such as growth factors, cytokines, and extracellular matrix components (Sarrazin et al., 2011, Cold Spring Harb Perspect Biol). The anionic charge of these membranes, contributed by both the sulfate groups on HSPGs and acidic phospholipids, facilitates the initial electrostatic recruitment of cationic molecules, including cell-penetrating peptides and viral attachment proteins (Magzoub & Gräslund, 2004, Q Rev Biophys). Many viruses, such as SARS-CoV-2, HIV-1, and Herpes Simplex Virus, utilize HSPGs as primary attachment receptors to concentrate viral particles on the cell surface before engaging specific entry receptors (Cagno et al., 2019, Rev Med Virol). In therapeutic contexts, these structures are targeted by polyanionic mimetics or cationic peptides to block viral infection, inhibit tumor angiogenesis, or facilitate the delivery of macromolecular drugs (Wadajkar et al., 2013, J Control Release).
Competitive inhibition of ligand binding to heparan sulfate chains and electrostatic neutralization of anionic membrane surfaces to prevent viral or molecular entry.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-surface anionic membranes and heparan sulfate proteoglycans (HSPG).